Consistently, silencing PBRM1 significantly increased CD8+ tumor‐infiltrating T lymphocytes (TILs), which could be reversed by clearance of macrophages (Figure 4L–N; Figure S4G, Supporting Information). The gene discussed is PBRM1; the disease is neoplasm.